Renal: Benign Prostatic Hyperplasia: Free MSRA Podcast

🎧 FREE MSRA PODCAST – Benign Prostatic Hypertrophy (BPH): The Ageing Prostate Explained!Struggling to memorise all you need for BPH? This episode brings together the essential UK NICE-aligned facts, pathophysiology, investigations, management, and classic pitfalls—stripped down for MSRA revision and clinical practice!🧠 Key Learning PointsDefinition• BPH = Benign (non-cancerous) increase in the number (hyperplasia, not hypertrophy) of glandular and stromal cells in the prostate, causing enlargement and compression of the urethra.• Results in lower urinary tract symptoms (LUTS) – but LUTS is NOT specific to BPH!Causes & Risk Factors• Driven by hormonal changes, especially increased dihydrotestosterone (DHT) relative to testosterone• Biggest risk factor: Ageing (commonest after 50, rare before 45)• Others: Family history, obesity, diabetes, heart disease, hormonal imbalances• Mnemonic: "A Family DHOH" (Age, Family, Diabetes, Heart, Obesity, Hormones)Pathophysiology• Hyperplasia (not hypertrophy!) in the transition zone around the urethra causes physical narrowing, increasing resistance to urine flow• Symptoms arise from bladder outflow obstructionDifferential Diagnosis• Must exclude prostate cancer!• Others: UTI, bladder stones, strictures, bladder tumours, neurogenic bladder, chronic prostatitisEpidemiology (UK)• ~50% of men over 50 have histological BPH• 40% of men in their 50s report symptoms; up to 90% by age 90• Afro-Caribbean men at higher riskClinical Features• Storage symptoms: Frequency, urgency, nocturia• Voiding symptoms: Hesitancy, weak stream, straining, terminal dribble, incomplete emptying• May lead to urinary retention, overflow incontinence, recurrent UTIs, bladder stones, and (rarely now) CKDDiagnosis• History and IPSS score• DRE: Smooth, firm, enlarged prostate = BPH; hard/nodular = suspect cancer• Urine dip: Exclude infection, check for blood• PSA: To help rule out cancer• Ultrasound: Assess prostate size, post-void residual, kidney/bladder health• Uroflowmetry: Peak flow <10ml/s suggests obstruction• Refer immediately for: Acute retention, AKI• Two-week referral: Visible haematuria, suspicion of cancer, chronic retention with overflowManagement• Lifestyle first: Fluid management, limit alcohol/caffeine, double voiding, physical activity• Medications:– Alpha-blockers (tamsulosin, alfuzosin): Relax smooth muscle, improve flow– 5-alpha reductase inhibitors (finasteride, dutasteride): Shrink gland by lowering DHT– Anticholinergics (oxybutynin): For storage symptoms (avoid if high PVR)• Surgery:– TURP (gold standard), HoLEP (laser), Urolift, Rezum, open prostatectomy for very large glands• Complications: Recurrent UTIs, bladder stones, retention, CKD (rare), haematuria• BPH is NOT pre-malignant! It does not increase cancer risk.Memory Aids• “Old men pee often, but not always well”• BPH = “Bulk Produces Hesitation” (Bulk = hyperplasia, Produces Hesitation = voiding difficulty)📎 More BPH Revision Resources:📝 Revision Notes: https://www.passthemsra.com/topic/benign-prostatic-hypertrophy-bph-revision-notes/💬 Flashcards: https://www.passthemsra.com/topic/benign-prostatic-hypertrophy-bph-flashcards/🧠 Q&A Notes: https://www.passthemsra.com/topic/benign-prostatic-hypertrophy-bph-accordion-qa-notes/📝 Rapid Quiz: https://www.passthemsra.com/topic/benign-prostatic-hypertrophy-bph-rapid-quiz/🎯 Quiz Portal: https://www.passthemsra.com/quizzes/benign-prostatic-hypertrophy/📚 Renal Course: https://www.passthemsra.com/courses/renal-for-the-msra/🏷️ #MSRA #BenignProstaticHypertrophy #BPH #LUTS #Prostate #Urology #Renal #MSRARevision #MSRAFlashcards #MSRAQandA #ProstateHealth #TURP #Urolift #Rezum #HoLEP #ProstateCancer #PassTheMSRA #FreeMSRA #UKGuidelines